0001209191-13-057433.txt : 20131217 0001209191-13-057433.hdr.sgml : 20131217 20131217170305 ACCESSION NUMBER: 0001209191-13-057433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131213 FILED AS OF DATE: 20131217 DATE AS OF CHANGE: 20131217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHROTRIYA RAJESH C MD CENTRAL INDEX KEY: 0001193918 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 131282827 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-13 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001193918 SHROTRIYA RAJESH C MD 11500 S. EASTERN AVE. SUITE 240 HENDERSON NV 89052 1 1 0 0 Chairman, CEO & President Common Stock, $0.001 par value 2013-12-13 4 A 0 80000 0.00 A 1878303 D Common Stock, $0.001 par value 23136 I By 401(k) plan Common Stock, $0.001 par value 57177 I By Shrotriya Family Foundation Common Stock, $0.001 par value 445993 I By CS Family Trust Common Stock, $0.001 par value 10676 I By Shrotriya Gift Trust Common Stock, $0.001 par value 9523 I By Spouse Stock Option (Right to Buy) 9.18 2013-12-13 4 A 0 650000 0.00 A 2013-12-13 2023-12-13 Common Stock 650000 650000 D 50% of the restricted shares will vest on June 13, 2014. The remaining 50% of restricted shares will vest on December 13, 2014. 25% of the option shares vested on December 13, 2013. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. /s/ Kurt A. Gustafson, attorney-in-fact for Rajesh C. Shrotriya 2013-12-17 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY



AUTHORIZATION


I hereby authorize Joseph K. Keller, Abraham N. Oler, Kurt A. Gustafson or Brett
L. Scott,
acting singly, to sign and file on my behalf any and all forms required by the
Securities
and Exchange Commission pursuant to Section 16 of the Securities Exchange Act of
1934
(the "Exchange Act") relating to the reporting of beneficial ownership of equity
securities
of Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and
of changes
in such beneficial ownership, together with any and all amendments thereto.
This authorization
shall be effective on and after the date set forth below and shall continue in
effect until
I am no longer required to file such forms, unless earlier revoked by me in
writing.

I acknowledge that the persons authorized hereunder are not assuming, nor is the
Company
assuming, any of my responsibilities to comply with Section 16 of the Exchange
Act.

Dated as of this 3rd day of December, 2013.



						/s/ Rajesh C. Shrotriya
						Rajesh C. Shrotriya